Girls who exhibited signs of polycystic ovary syndrome -- those with very low birth weight and who developed pubic hair at a very early age -- who took the diabetes drug metformin every day from ages 8 to 12 had a reduced risk of fertility problems by age 15 compared with counterparts who took the medication for one year starting at age 12, a study in the Journal of Clinical Endocrinology and Metabolism found. Researchers are conducting a follow-up to see if the risk reduction would persist until age 18.
The California Endowment and partner agencies have launched a $200 million loan program in an effort to curb obesity in low-income neighborhoods. The program aims to bring more stores to underserved areas to increase the amount of affordable fresh produce in those areas.
Electronic health record systems designed for small practices received the highest satisfaction ratings among 30 systems in a survey by the American Academy of Family Physicians. The group's members rated systems in areas such as ease of ordering lab tests and doctors' confidence in being able to meet federal standards to earn EHR incentives. The four top-rated systems were Medent from Community Computer Service, Amazing Charts, e-MDs and Praxis from Infor-Med.
Using an automated decision support tool and glucose data training helped improve glycemic data interpretation among clinicians, an Accu-Chek DECIDE study found. Participants who used both approaches fared better in identifying glycemic abnormalities compared with those who only received either structured blood glucose monitoring data or educational DVD outputs, experts said.
Two major diabetes groups, saying there is not enough research on the subject, have questioned whether the medical condition, which is seen by some as a precursor of cardiovascular issues, actually exists. Analysts say the groups' position as a setback for Sanofi-Aventis, which reportedly hopes to market its new anti-obesity drug Acomplia also as a treatment for "metabolic syndrome."